Therapeutic designer enzymes repairing the molecular damage of aging and age-related disease
Revel Pharmaceuticals is reimagining how enzymes can be used as therapeutics by developing repair-based approaches to aging and disease.
A collection of harmful chemical reactions occur in aging and disease.
The toxic chemical byproducts of these reactions build up in the body over time, modifying and crosslinking proteins, and driving a variety of age-related diseases.
Enzymes can repair the damage and reverse the course of disease. By addressing one of the hallmarks of aging, Revel is strategically positioned to develop therapeutics for multiple diseases of aging.